 |
Previous Article | Next Article 
The Journal of Neuroscience, May 15, 2001, 21(10):3419-3428
Suppression of Neuronal Hyperexcitability and Associated Delayed
Neuronal Death by Adenoviral Expression of GABAC
Receptors
Qing
Cheng1,
John C.
Kulli2, and
Jay
Yang1, 2
Departments of 1 Pharmacology and Physiology and
2 Anesthesiology, University of Rochester Medical Center,
Rochester, New York 14642
 |
ABSTRACT |
The excessive neuronal excitation underlying several clinically
important diseases is often treated with GABA allosteric modulators in
an attempt to enhance inhibition. An alternative strategy would be to
enhance directly the sensitivity of postsynaptic neurons to GABA. The
GABAC receptor, normally found only in the retina, is more
sensitive to GABA and demonstrates little desensitization compared with
the GABAA receptor. We constructed an adenovirus vector
that expressed cDNA for both the GABAC receptor
1 subunit and a green fluorescent protein (GFP)
reporter and used it to transduce cultured hippocampal neurons.
Transduced neurons were identified by fluorescence, double
immunocytochemistry proved colocalization of the 1
protein and the reporter, Western blot verified the expected molecular
masses, and electrophysiological and pharmacological properties
confirmed the presence of functional GABAC receptors.
1-GFP transduction resulted in an increased density of
GABAA receptors as well as expression of novel
GABAC receptors. This effect was not reproduced by addition
of TTX or Mg2+ to the culture medium to reduce
action potentials or synaptic activity. In a model of neuronal
hyperexcitability induced by chronic blockade of glutamate receptors,
expression of GABAC receptors abolished the hyperactivity
and the consequent delayed neuronal death. Adenovirus-mediated neuronal
GABAC receptor engineering, via its dual mechanism of
inhibition, may offer a way of inhibiting only those hyperexcitable
neurons responsible for clinical problems, avoiding the generalized
nervous system depression associated with pharmacological therapy.
Key words:
GABAC receptors; hippocampal neurons; adenovirus; hyperexcitability; cell culture; delayed neuronal death
 |
INTRODUCTION |
Enhancement of inhibitory neuronal
activity may be beneficial for treating CNS diseases
characterized by excessive excitation. Experimental models of
epilepsy, for example, demonstrate a decrease in hippocampal
GABAA receptor expression (Friedman et al., 1994 ; Rice et al., 1996 ) and function (Gibbs et al., 1997 ), suggesting that
loss of inhibitory control plays a pathogenic role (Mody, 1998 ).
Postischemic and traumatic neuronal death is reduced by the GABA
potentiator diazepam (Schwartz et al., 1995 ; O'Dell et al., 2000 ).
Enhancement of the GABA effect at the receptor is a reasonable strategy
for increasing inhibition; this is the mechanism of many clinically
useful drugs including anticonvulsants, anxiolytics, and general
anesthetics (Hevers and Luddens, 1998 ). An alternative to receptor
modulation is changing the number or type of GABA receptors, with
consequent suppression of hyperexcitability. In epilepsy, in which
relatively few hyperexcitable neurons are responsible for the
initiation of seizures, overexpression of GABA receptors restricted to
those few neurons might enhance inhibition with fewer side effects than
conventional systemic pharmacotherapy (Jallon, 1997 ; Loscher,
1998 ).
The common ionotropic GABAA receptor is a
pentamer formed of a combination of , , and
subunits. Binding of the ligand GABA opens the integral chloride
ion channel, driving the membrane potential toward the chloride
equilibrium potential and thus reducing sensitivity to excitatory
neurotransmitters. The rarer GABAC receptor, another member of the inotropic GABA receptor family, is a homomeric assembly of 1 subunits (Shimada et al., 1992 ;
Amin and Weiss, 1996 ); a search for endogenous mRNA using reverse
transcription-PCR found 1 only in bipolar
cells of the retina (Boue-Grabot et al., 1998 ), although other
types of subunits are found elsewhere in the CNS (Wang et al.,
1994 ; Enz and Cutting, 1999 ). Recent evidence that
1 subunits do not coimmunoprecipitate in
vitro with 1, 5,
or 1 subunits of GABAA
suggests that 1 subunits do not associate with
GABAA subunits to form receptors (Hackam et al.,
1998 ). Pharmacologically, the GABAC receptor is
characterized by insensitivity to the GABAA
antagonist bicuculline and to the GABAB agonist
baclofen (Bormann and Feigenspan, 1995 ; Bormann, 2000 ). Compared with
the GABAA receptor, the
GABAC receptor is 40 times as sensitive to GABA,
is much slower, requiring eight times as long to activate and
deactivate, and shows little or no desensitization (Amin and Weiss,
1994 ). Because of these favorable properties, forced expression of
GABAC receptors should significantly enhance the
effects of GABA in hyperexcitable neurons.
Adenovirus can transduce hippocampal neurons both in slice and in
culture with high efficiency (Wilkemeyer et al., 1996 ;
Griesbeck et al., 1997 ) and, at least in the short term, without
affecting electrical excitability or synaptic transmission (Smith et
al., 1997 ; Lissen et al., 1998 ; Johns et al., 1999 ). We report the use,
in cultured hippocampal neurons, of a replication-deficient adenovirus
designed to express cDNA encoding the GABAC
receptor 1 subunit. Overexpression of the
1 subunit should result in formation of
GABAC receptors with predictable pharmacological properties and without disruption of the native
GABAA receptors.
 |
MATERIALS AND METHODS |
Rat primary hippocampal culture. Sprague Dawley rat
pups (1- to 2-d-old) were decapitated, and the hippocampi were
dissected out in ice-cold HBSS (Life Technologies, Gaithersburg,
MD). The tissue was enzymatically digested with papain and bovine serum albumin (each at 1 mg/ml; Sigma, St. Louis, MO) for 20 min at 37°C.
Cells were disaggregated by trituration and plated on Matrigel-coated 35 mm tissue culture plates (Becton Dickinson, Bedford, MA) in Neurobasal medium (Life Technologies) supplemented with 2 mM L-glutamine, 10% fetal calf serum (HyClone,
Logan, UT), 5% horse serum, and B-27 supplement (Life Technologies).
After 2-3 d of growth in a 95% O2-5%
CO2 humidified incubator at 37°C, the dishes
were treated with 10 µM cytosine arabinoside for 24 hr to
suppress the growth of glia. Thereafter, the medium was switched to a
Neurobasal medium containing 5% horse serum and changed every 2-4 d
until the cultures were used for experiments.
Induction of neuronal hyperexcitability. Dissociated
hippocampal neurons grown with glutamate receptors and synapses
chronically blocked (>14 d) by kynurenate (1 mM) and
magnesium (10 mM MgCl2) became
hyperexcitable; when the kynurenate-Mg2+
medium was replaced by a control salt solution without the blockers, neurons displayed seizure-like activity, consisting of bursts of action
potentials riding on paroxysmal depolarization shifts (Furshpan and
Potter, 1989 ).
Recombinant adenovirus. The recombinant E1- and E3-deleted
replication-deficient human adenovirus type-5 was created via
homologous recombination between the pXCR shuttle vector and the
pBHG10 parent vector (Bett et al., 1994 ). So that the
1 subunit and green fluorescent protein (GFP)
proteins would be expressed independently, the shuttle vector was
modified to contain two expression cassettes, both driven by the Rous
sarcoma virus promoter followed by a multiple cloning site and a
polyadenylation sequence. GFP cDNA was subcloned into the first
cassette, and human 1 subunit cDNA (a gift of Dr. Gary Cutting, Johns Hopkins University, Baltimore, MD) was subcloned into the second. The pBHG10 plasmids and the shuttle vector
containing the transgene were cotransfected into human embryonic kidney
293 (HEK293) cells using the Ca-phosphate method (Life Technologies).
Lytic plaques were isolated and expanded, and the presence of the
transgene and the absence of the E1 gene were confirmed by PCR.
High-titer adenovirus, twice purified by CsCl gradient centrifugation,
was stored as a 10% glycerol suspension at
80Co. The titer of each adenovirus
preparation was determined by counting GFP-positive plaques formed in a
virus-transduced confluent HEK293 monolayer overlaid with low-melt
agarose. Because the number of viable cells in a culture dish was
unknown, we report the concentration of virus used for transduction of
cultured cells as plaque-forming units (pfu) per milliliter rather than
as pfu per cell. pBHG10 and pXCR plasmids were purchased from Microbix
(Toronto, Ontario, Canada).
Whole-cell recording and data collection. Patch electrodes
were pulled from 1.2-mm-outer-diameter borosilicate capillary glass (WPI, Sarasota, FL) and fire polished. The electrodes had a typical resistance of 5-10 M when filled with intracellular solution. For
voltage-clamp experiments the solution was composed of (in mM): 140 CsCl, 4 NaCl, 2 MgCl2, 10 K-EGTA, and 10 HEPES. For current-clamp recordings of action
potentials, 140 mM K-gluconate replaced CsCl. Solutions
were titrated to pH 7.3 with CsOH or KOH and supplemented with 2 mM Mg-ATP. The external solution contained (in
mM): 140 NaCl, 2.8 KCl, 1 MgCl2, 3 CaCl2, 10 HEPES, and 10 glucose; the solution was
titrated to pH 7.4 with NaOH. Recordings were made using an AxoPatch
200A amplifier (Axon Instruments, Foster City, CA). A typical access
resistance of ~15 M in the whole-cell mode of patch clamp was
compensated by 75%. Cell input capacitance was approximated by reading
the capacitance compensation dial of the amplifier. Recorded membrane
currents were filtered at 5 kHz, digitized using Clampex v8.0,
and analyzed with Clampfit v6.0 (Axon Instruments). Kinetic
parameters were determined by simultaneously fitting a monoexponential
rising phase (activation) and biexponential decay phase
(desensitization) to the evoked current from the beginning to the end
of the duration of drug application. A separate monoexponential decay
function was fit to the deactivation phase of the current after washout
of GABA. A syringe pump delivered external solutions at 15 ml/hr
through orifices of a tube mounted on a piezoelectric transducer
(Burleigh Instruments, Fishers, NY). Command steps at 120 sec intervals rapidly moved the perfusion ports, exposing the cell to either the
control or the drug solution. The perfusion device allowed exchange of
solution in ~15 msec (10-90% rise time) for the whole-cell recording configuration. Because of the limited exchange rate, the
kinetic parameters determined should be considered approximate and to
represent only the upper limit of the true process. For antagonist
applications, GABA and the antagonist were applied simultaneously.
Because GABA binding to its receptor is rather slow (Jones et al.,
1998 ), rapid equilibrium should be established well within the time
scale of tens of milliseconds relevant to our study even without
antagonist preexposure. All experiments were performed at room
temperature (20-25Co); all drugs were
purchased from Sigma.
Assay for delayed neuronal death. Unopposed neuronal
hyperactivity was induced by replacing the
kynurenate-Mg2+ medium in chronically
blocked cultures with one without the blockers for a variable time
between 15 min and 24 hr. At 24 hr after the initiation of
hyperexcitability, delayed neuronal death was determined by ethidium
homodimer staining (2 µM for 5 min at room temperature). Neuronal injury allows ethidium homodimer to penetrate and intercalate into DNA to yield a bright red fluorescence. The stained culture dishes
were examined under an epifluorescence microscope (Olympus IX50), and
images of random fields were captured (Dage RC300; Dage-MTI, Michigan
City, IN; Scion Imager V3.0; Scion Corporation, Frederick, MD) under
both phase-contrast and fluorescent lighting. Phase-contrast images,
which do not reveal cell death, were captured first to avoid bias in
sampling. Live and dead neurons (100 total) were counted off-line from
the captured images to determine the proportion of dead cells.
Immunocytochemistry. Cells grown on glass coverslips were
fixed in ice-cold acid methanol (95% methanol and 5% acetic acid) for
10 min and permeabilized in PBS containing 0.2% Triton X-100 (PBST). The cells were blocked in PBST with 10% serum for 10 min, and
all subsequent reactions were performed in PBST with 2% serum. Rabbit
anti- 1 polyclonal antibody raised against an
epitope of human 1 peptide conjugated with
keyhole limpet hemocyanin (QRQRREVHEDAHK) (Hackam et al., 1997 ) was
prepared and affinity purified by Genemed Synthesis (South San
Francisco, CA). Double immunohistochemical staining for GFP and
1 subunit proteins was accomplished by
overnight simultaneous primary antibody exposure [1:200 mouse anti-GFP
(Boehringer Mannheim, Indianapolis, IN) and 1:50 rabbit
anti- 1 antibodies] at
4Co followed by exposure for 1 hr at room
temperature (RT) to anti-mouse IgG-FITC and anti-rabbit IgG-rhodamine
secondary antibody (both at 1:200). Captured images were pseudocolored
for the final figures using Adobe Photoshop.
Western blot analysis. HEK293 cells were transduced
with the same virus used for neuronal transduction. After 24 hr the
majority of the cells were brightly fluorescent but had not yet
developed a cytopathic appearance. At this time the cells were scraped
off with cold PBS, pelleted, and resuspended in ice-cold lysis buffer (1% NP-40, 50 mM NaCl, 30 mM Na pyrophosphate,
30 mM NaF, and 10 mM Tris HCl, pH 7.6)
containing 1× proteinase inhibitor cocktail (Boehringer Mannheim).
After a 30 min incubation in the lysis buffer on ice and centrifugation
at 14,000 rpm for 20 min at 4 Co, the
supernatant was aspirated and quantified for protein and then separated
by a 10% SDS-PAGE. After an overnight transfer onto nitrocellulose and
block in 5% milk in TBS plus Tween (TBST) for 1 hr at RT,
paired lanes of control and transfected samples were probed with mouse
anti-GFP antibody (1:500) and rabbit anti- 1 antibody (1:100), all in 2% milk-TBST, for 2 hr at RT.
1-Antibody-specific blocking peptide (25 µg/ml) was added to the
primary antibody for the blocking peptide experiment. After three
washes and a secondary antibody exposure [goat anti-mouse IgG-HRP
(Bio-Rad, Hercules, CA) or cat anti-rabbit IgG-HRP (Santa Cruz
Biotechnology, Santa Cruz, CA); both at 1:1000] for 1 hr at RT, the
membrane was reacted with a chemiluminescent substrate (NEN Life
Sciences, Boston, MA), and an image was obtained by exposing an x-ray
film. The final figure was obtained by digitizing the x-ray film and composing the images using Adobe Photoshop.
 |
RESULTS |
Recombinant adenovirus expression of GABA 1 subunits
in cultured hippocampal neurons produces functional GABAC
receptors
We constructed two recombinant adenoviruses (Ads). The control
Ad-GFP expressed only the GFP reporter; the other,
Ad- 1-GFP, coexpressed both GFP and the
GABAC 1 subunit.
Hippocampal neuron cultures were transduced with a range of
concentrations of the two viruses. After 24 hr at 1 × 10 5 pfu/1
ml, between 10 and 20% of cells exhibited GFP fluorescence with no
apparent effect on the morphology of live neurons (Fig. 1A). This was the
highest concentration at which neurons showed no gross
morphological abnormalities and few non-neuronal cells (e.g., glia)
were transduced. Double-immunocytochemical staining of
Ad- 1-GFP-transduced neurons
( 1-GFP-neurons) demonstrates 1 and GFP immunoreactivity in the same cells
(Fig. 1B). The GFP immunoreactivity is distributed
diffusely throughout the cell in both
1-GFP-neurons and control Ad-GFP-transduced
neurons (GFP-neurons). In contrast, 1
immunoreactivity was found only in
1-GFP-neurons. Comparable
1 immunoreactivity in dendrites could not be
discerned with certainty.

View larger version (38K):
[in this window]
[in a new window]
|
Figure 1.
Adenovirus-mediated expression of functional
GABAC receptors in cultured hippocampal neurons.
A, Phase-contrast (top) and
GFP-fluorescent (bottom) image pairs of
Ad-GFP-transduced or Ad- 1-GFP-transduced (both at 1 × 10 5 pfu/ml) live cells.
GFP-positive cells (examples shown by white arrows) are
transduced. B, Anti-GFP-antibody-reactive
(top) or anti- 1-antibody-reactive
(bottom) fluorescent views of the same field from
cultures 48 hr after viral transduction. White arrows
point to the virally transduced neurons immunoreactive for GFP. The
1-GFP-neuron is also immunoreactive to
anti- 1 antibody. C, Western blot of
detergent-extracted membrane (top) and soluble
(bottom) fractions of HEK293 cells transduced with
Ad- 1-GFP (lanes 1, 3) or Ad-GFP
(lanes 2, 4). The relative molecular masses are
denoted on the right. D, Whole-cell
patch-clamp recordings from transduced neurons. The left
traces are from GFP-neurons, and the right
traces are from 1-GFP-neurons.
Vh = 50 mV. Drug applications are denoted by the
black horizontal bar. E, Current-voltage
relationship (bottom graph) obtained from
1-expressing neurons recorded with high
(left) or low (right) intracellular
chloride concentrations. Arrows point to the
reversal potentials. The expected shift in Nernst chloride potential
because of the ionic conditions used was 72 mV. Scale bar: A,
B, 150 µm.
|
|
To confirm the expression of proteins of the expected molecular mass,
we transduced HEK293 cells with the same viral constructs. Figure
1C, a Western blot of the membrane fraction harvested 24 hr
after viral transduction, demonstrates an
anti- 1 antibody immunoreactive band at 60 kDa
consistent with the expected molecular mass of the
1 subunit. Identification of this band is
confirmed by its disappearance in the presence of a specific
anti- 1-antibody-epitope blocking peptide. A separate protein band at
25 kDa, corresponding to the GFP reporter protein, can also be seen in
the soluble fraction; it is not sensitive to the blocking peptide.
Electrophysiological properties of
1-GFP-neurons, control GFP-neurons, and
nonfluorescent neurons were measured by whole-cell patch clamp. Control
GFP-neurons were activated by GABA but not by
cis-4-aminocrotonic acid (CACA), a
GABAC-receptor-selective agonist (Fig.
1D). In contrast, both GABA and CACA evoked currents in 16 of 17 fluorescent 1-GFP-neurons. As
expected, the CACA-evoked current was kinetically distinct from the
GABA-evoked current; activation and deactivation were slow, and there
was no significant desensitization. The CACA-evoked current in
1-GFP-neurons demonstrated a linear
current-voltage (I-V) relationship with a reversal
potential shift (2.4 ± 0.7 mV with symmetric chloride
concentrations and 58 ± 1.4 mV with a low internal chloride
concentration) consistent with a current carried by the chloride ion
(Fig. 1E). These properties are characteristic of
current mediated by GABAC receptors (Bormann and
Feigenspan, 1995 ). CACA failed to evoke current in nonfluorescent neurons (n = 14) from the same culture dish (data not
shown). We conclude that 1-GFP-neurons possess
functional GABAC receptors.
Kinetic properties of GABAA receptors are not modified
by expression of GABAC receptors in the same neuron
It is possible that the simultaneous expression of both
GABAA and GABAC receptors
in the same neuron might alter their kinetic properties. Alternatively,
the GABAA and GABAC
receptors may function independently and maintain their respective
kinetic properties even when coexpressed together. We examined the time
course of GABA-gated currents in transduced neurons. In control
neurons, with only GABAA receptors, the time
course of GABA-gated current was well fit by the expected
monoexponential activation, biexponential desensitization, and
monoexponential deactivation functions [Figs. 2, left column, top
(no virus) and middle (GFP) rows,
3]. GABA-gated current in
1-GFP-neurons, with both
GABAA and GABAC receptors, is shown in Figure 2 (left column, bottom row).
The slower desensitization and deactivation in comparison with those of
the GABAA-only response are readily apparent. The
GABAA-selective antagonist bicuculline blocked
responses to GABA in control neurons and changed the kinetics of the
1-GFP-neurons to the slowly activating and
deactivating current typical of GABAC receptors
(Fig. 2, middle column). In contrast, the
GABAC-selective antagonist imidazole-4-acetic
acid (I4AA) had no effect on control neuron kinetics but returned the kinetics of the 1-GFP-neurons to that of
GABAA alone (Fig. 2, right column).
Figure 3 shows current traces at expanded time scales to emphasize the
kinetic differences between GABAA and GABAC receptor-gated currents. Currents from
nontransduced, GFP-neuron, and 1-GFP-neuron in the presence of I4AA
superimposed, qualitatively demonstrating no kinetic effect of viral
transduction in itself. Current from a 1-GFP-neuron in the presence
of bicuculline demonstrated distinct kinetic signatures. Both
GABAA (Fig. 3D) and
GABAC (Fig. 3E) receptor-mediated
components of 1-GFP-neuron were well described by a triexponential
activation/desensitization and monoexponential deactivation kinetic
model. Parameters of the kinetic fits to the pharmacologically
separated currents within the resolution of our limited drug
application system are shown in Table
1.

View larger version (16K):
[in this window]
[in a new window]
|
Figure 2.
Pharmacological separation of GABAA
receptor- and GABAC receptor-mediated current components.
Currents evoked by applications of 100 µM GABA alone
(left column) or in the presence of 100 µM
bicuculline (Bicuc; middle column) or 50 µm I4AA (right column). The three drug trials for each
row are from the same cell. The representative current
records are from neurons not transduced with virus (top
row) or transduced with Ad-GFP (middle row) or
Ad- 1-GFP (bottom row). The duration of drug
application is denoted by the black horizontal lines
above the first row of traces.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Figure 3.
Kinetic properties of GABA-evoked currents in
virally transduced hippocampal neurons. A-C, GABA (100 µM)-evoked currents shown at different time resolutions
to emphasize the activation (A), desensitization
(B), and deactivation (C)
phases. The superimposed traces are from nonfluorescent
neurons, GFP-neurons, and 1-GFP-neurons with
coapplication of 50 µM I4AA or 100 µM
bicuculline. The peaks of the current traces have been
normalized to demonstrate better the kinetic properties of the
currents. The kinetically distinct current is from a
1-GFP-neuron with coapplication of GABA and bicuculline,
whereas the remaining three traces superimpose.
D, E, A kinetic fit of a triexponential
( act, des1, and
des2) function to the activation and
desensitization phases and a separate monoexponential
( deact) function fit to the current deactivation.
The two traces are both from
1-GFP-neurons with GABA coapplied either with I4AA
(D) (i.e., the GABAA component) or
with bicuculline (E) (i.e., the GABAC
component). See Table 1 for summary of kinetic parameters.
|
|
GABAC receptors inhibit hyperexcitable
hippocampal neurons
Ordinarily, hippocampal neurons grown in standard culture
conditions exhibit modest levels of spontaneous activity; we observed 0.97 ± 0.32 action potentials/sec, as shown in Figure
4A (n = 8). Neurons cultured under conditions of chronic kynurenate blockade of
glutamate receptors and chronic Mg2+
blockade of synapses were hyperexcitable (Furshpan and Potter, 1989 ).
After removal from chronic blockade, these neurons exhibited spontaneous action potential bursts, typically 300-500 msec long, riding on a wave of depolarization reminiscent of the paroxysmal depolarization shifts seen in epileptic foci in vivo and
in vitro (Fig. 4B). The mean action
potential rate was 5.5 ± 1.03 sec 1; the
rate during bursts approached 20 sec 1. This
seizure-like electrical hyperexcitability occurred in 11 of 12 neurons
examined.

View larger version (31K):
[in this window]
[in a new window]
|
Figure 4.
Expression of 1 subunit suppresses
spontaneous action potentials in the
kynurenate-Mg2+ model of hyperexcitable neurons.
A, A representative whole-cell current-clamp recording
from a hippocampal neuron grown under standard cell culture conditions.
The bottom trace is an expanded view of the region
denoted by the black bar. B-D, Neurons
rendered hyperexcitable by kynurenate-Mg2+
treatment (B) and transduction with Ad-GFP
(C) or Ad- 1-GFP
(D). E, Action potential firing
rate for the same cells shown above demonstrating the stability of
excitability over time (nontransduced hyperexcitable neurons,
black circles; Ad-GFP-neurons, white
circles; Ad- 1-GFP-neurons, black inverted
triangles; and control nontreated, nontransduced neurons,
white inverted triangles). F, A bar graph
of average action potential frequency for the four conditions
(n = 8-20 neurons for each). Kyn,
Kynurenate.
|
|
Hyperexcitable neuron cultures were transduced with either
Ad- 1-GFP or the control Ad-GFP. After 2-6 d,
whole-cell patch-clamp recording was established in neurons expressing
GFP. To avoid shifting the chloride reversal potential to a more
positive value and thus artifactually enhancing excitability, a low
chloride ion internal solution was used. After an initial 1-2 min
settling period, action potential firing patterns were stable for at
least 20 min for both control and transduced neurons (Fig.
4E). Action potential rates were determined from a 5 min data collection window after stabilization. Typically, control
GFP-neurons exhibited the paroxysmal action potentials characteristic
of nontransduced hyperexcitable neurons (Fig. 4C). In
contrast, 1-GFP-neurons exhibited
low-frequency spontaneous action potentials without evidence of
bursting (Fig. 4D).
Pooled data from several experiments demonstrate large differences in
spontaneous action potential rates: nontransduced, 5.4 ± 1.0 sec 1; after
Ad-GFP, 5.8 ± 0.9 sec 1; and
after Ad- 1-GFP, 0.48 ± 0.08 sec 1 (Fig.
4F). The spontaneous action potential frequency of
hyperexcitable neurons treated with Ad- 1-GFP
was comparable with that of control neurons. Thus
Ad- 1-GFP transduction reverses neuronal
hyperexcitability in the
kynurenate-Mg2+-blockade-induced model of epilepsy.
Both GABAA and GABAC receptors participate
in suppression of hyperexcitability in Ad- 1-GFP-transduced
hippocampal neurons
We then evaluated the effects of selectively activating
GABAA and GABAC receptors
in hyperexcitable neurons. Figure
5A (left) shows
that nontransduced neurons (top), GFP-neurons
(middle), and 1-GFP-neurons
(bottom) all responded to GABA (30 µM) with membrane hyperpolarization and acute
inhibition of spontaneous action potentials. In nontransduced and
control neurons, this presumably occurred via activation of
constitutively present GABAA receptors, whereas
in 1-GFP-neurons, GABA activated both
GABAA and GABAC receptors.
Figure 5A (right) shows that the
GABAC-selective agonist CACA (100 µM) had no effect on nontransduced
(top) or GFP-neurons (middle), but in
1-GFP-neurons (bottom), CACA
caused membrane hyperpolarization and suppressed action potentials
in those few neurons with spontaneous firing.

View larger version (30K):
[in this window]
[in a new window]
|
Figure 5.
Pharmacological properties of hyperexcitable
hippocampal neurons. A, Whole-cell current-clamp
recordings from control nontransduced neurons (top),
Ad-GFP-neurons (middle), or
Ad- 1-GFP-neurons (bottom) exposed to GABA
(left) or CACA (right) are shown.
Black horizontal lines denote the duration of drug
application. B, GABAC antagonist I4AA,
GABAA antagonist bicuculline, I4AA + bicuculline, or the
nonspecific GABA antagonist picrotoxin were applied to
Ad- 1-GFP-transduced
kynurenate-Mg2+-treated neurons. A summary bar
diagram (bottom) of the relative action potential
frequency during GABA antagonist applications (n = 6-12 neurons for each) is shown. No statistically significant
difference (ns, p > 0.05) was found
except for I4AA + Bicuc and picrotoxin
(PTXN).
|
|
We also examined the effect of blockade of GABAA
and GABAC receptors on
1-GFP-transduced hyperexcitable neurons. As
expected, selective blockade of GABAA receptors
with bicuculline failed to increase spontaneous firing. Surprisingly,
selective blockade of GABAC receptors with I4AA
also failed to increase spontaneous firing. That is, I4AA did not
reverse the suppression of hyperexcitability that followed
Ad- 1-GFP transduction. After coapplication of
both bicuculline and I4AA or application of the nonselective GABA
receptor antagonist picrotoxin (50 µM) alone, blocking
both GABAA and GABAC receptors, the seizure-like electrical activity returned (Fig. 5B). Thus it appears that
Ad- 1-GFP-induced expression of
GABAC receptors somehow enhances endogenous
GABAA receptor-mediated inhibition of neuronal excitability.
To examine further this apparent enhancement of
GABAA receptor activity, we studied
receptor-specific current density after Ad- 1-GFP transduction. Figure
6A shows
GABA-evoked current density (normalized by cell capacitance) from
nontransduced neurons (gray bars), GFP-neurons
(black bars), and 1-GFP-neurons (hatched bars) at 2 d intervals after viral transduction. The total current
density evoked by 100 µM GABA did not change
for control nontransduced neurons and GFP-neurons. In 1-GFP-neurons,
where the GABAC receptor number should be
increasing with time since transduction, total current density
increased, as expected. Pharmacological isolation of the
GABAC component of the total current density (by
bicuculline blockade of GABAA receptors)
confirmed this time-dependent increase in the
GABAC contribution (Fig. 6B,
triangles). Interestingly, pharmacological isolation of the
GABAA component (by I4AA blockade of
GABAC receptors) also showed a time-dependent
increase in the current density (Fig. 6B,
squares). In fact, the contribution of
GABAA receptors to the increase in total current
density was approximately equal to that of GABAC
receptors. Again the presence of GABAC receptors
seems to enhance GABAA receptor function.

View larger version (24K):
[in this window]
[in a new window]
|
Figure 6.
GABAA receptor-mediated current
density is enhanced after transduction with the 1-GFP virus.
A, Current density (peak current evoked by 100 µM GABA/cell input capacitance) at 2, 4, and 6 d
after transduction with no virus (gray bars),
Ad-GFP (black bars), or Ad- 1-GFP (hatched
bars). An asterisk denotes statistical
significance (Ad- 1-GFP vs no virus) at p < 0.02, 0.01, or 0.0001 for 2, 4, or 6 d, respectively. Ad-GFP
versus no virus was not significantly different at any time points
(p > 0.21). B,
Pharmacological separation of the total current (circle)
into GABAA (square) and GABAC
(triangle) components at different time points after
viral transduction. At the day 6 time point (asterisks),
both GABAA (p < 0.01) and
GABAC (p < 0.0001) components
were significantly greater compared with those on day 0. C, Current density of neurons grown for 6 d in the
control medium (Cont) supplemented as noted. Only
Ad- 1-GFP-transduced neurons demonstrated significantly greater
current density (p < 0.001). For
A-C, the numbers of cells are denoted in
parentheses.
|
|
It is possible that the apparent enhancement of
GABAA receptor function is the result of the
reduction in neuronal activity caused by transduction. It is well known
that neuronal activity (Penschuck et al., 1999 ) or depolarization as a
surrogate of neuronal activity (Gault and Siegel, 1997 , 1998 ) regulates
many neurotransmitter receptors, including the
GABAA receptors. If the change in neuronal activity alone is responsible, then similar changes in activity in
nontransduced neurons (by inhibition of electrical activity by TTX or
suppression of synaptic transmission by elevated
Mg2+) should mimic the action of
1-GFP-virus. If the changes are nonspecific
effects of viral transduction, the control GFP-virus should mimic the
effects of the 1-GFP-virus.
To preclude possible interactions between the chronic
kynurenate-Mg2+ growth condition and the
GABAA current density enhancement, the effects of
TTX, Mg2+, and viral transduction were
examined in neurons grown in otherwise normal culture medium. Neither
culturing the neurons for 6 d in TTX or
Mg2+-supplemented medium nor GFP-virus
transduction increased the GABAA current density
over that of control nontreated neurons (Fig. 6C).
Ad- 1-GFP transduction suppresses
hyperexcitability-induced delayed neuronal death
Prolonged unopposed excitation kills neurons (Abele et al., 1990 ;
Murray et al., 1998 ). Regardless of the precise mechanism, because
Ad- 1-GFP transduction of hyperexcitable
neurons decreases spontaneous activity, it may also decrease
hyper-excitability-associated excitotoxic delayed neuronal death.
To determine baseline excitotoxic neuronal death rates, we subjected
hyperexcitable neurons to paroxysmal electrical activity by replacing
the kynurenate-Mg2+ blocking medium with
a medium without blockers for 30 min and then restoring the blocking
medium. After 24 hr, 45-52% of the neurons were dead, as determined
by staining with ethidium homodimer. In control cultures subjected only
to sham wash, with no period of paroxysmal activity, only 1-5% of the
neurons were dead (Fig. 7A).
Increasing the duration of hyperexcitability increased delayed neuronal
death (Fig. 7B), consistent with a previous report (Murray et al., 1998 ). In three separate experiments, 2 d after
transduction, hyperexcitable 1-GFP-neurons
were subjected to the same 30 min period of
kynurenate-Mg2+ removal. After 24 hr,
54 ± 2% of the neurons were dead, not significantly different
from baseline. However, of the ~20% of neurons exhibiting GFP
fluorescence and that are thus certain to have been successfully transduced and to express the GABAC receptor,
only 1-5% were dead (Fig. 7C,D). Successful transduction
with Ad- 1-GFP provides nearly complete
protection from hyperexcitability-induced excitotoxic delayed neuronal
death in this model.

View larger version (67K):
[in this window]
[in a new window]
|
Figure 7.
Suppression of hyperexcitability-induced delayed
neuronal death. A, Phase-contrast and fluorescent image
pairs of a culture dish rendered hyperexcitable for 0 min
(top) or 30 min (bottom).
Arrows point to the ethidium-homodimer-positive dead
neurons. B, Summary bar diagram of the percentage of
neuronal death versus the duration of hyperexcitability.
C, Phase-contrast (top left), GFP
(bottom), and ethidium (top right) images
from an Ad- 1-GFP-transduced culture subjected to 30 min
of hyperexcitability. White arrows point to
nontransduced dead (i.e., GFP-negative and ethidium-positive) neurons,
and black arrows point to transduced live (i.e.,
GFP-positive and ethidium-negative) neurons. D,
Summary bar diagram of delayed neuronal death in control and
Ad- 1-GFP-transduced neurons from three separate
experiments (asterisk, significant at
p < 0.0001).
|
|
 |
DISCUSSION |
A recombinant adenovirus, Ad- 1-GFP,
designed to express both the GABA 1 subunit
and GFP was created. The coexpression of GFP allowed for an easy visual
identification of successfully transduced neurons. Immunocytochemical
study of individual GFP-positive neurons and a Western blot of virally
transduced HEK293 cells demonstrated the de novo expression
of 1 protein. The punctate pattern of the
membrane immunoreactivity could not be discerned, but because
hippocampal neurons abundantly express the microtubule-associated protein-1B (MAP-1B) (data not shown), aggregation into receptor patches
is expected (Hanley et al., 1999 ). The distinctive pharmacology of
GABAC receptors (insensitive to bicuculline,
sensitive to picrotoxin, selectively activated by CACA, and selectively
inhibited by I4AA) allowed for a definitive confirmation of the
presence of this receptor in
Ad- 1-GFP-transduced hippocampal neurons. As
expected, 1-GFP-neurons demonstrated
CACA-activated chloride-permeable channels with the threefold slower
activation and fivefold slower deactivation kinetics of functional
GABAC receptors. Of note is our preliminary
observation indicating a lack of bicuculline-resistant mIPSC in
1-GFP-neurons (Cheng and Yang, 2000 ). Although
we are unable to distinguish between the lack of functional versus
physical presence of synaptic GABAC receptors,
data thus far are consistent with the expression of abundant somatic
but not synaptic GABAC receptors.
Although previous studies have suggested the presence of a
bicuculline-resistant GABAC-like receptor in the
hippocampus during the first 2 weeks of postnatal development (Strata
and Cherubini, 1994 ) and 2 subunit mRNA
has been detected in postnatal day 5 and adult rat hippocampus by
Northern blot and reverse transcription-PCR analyses (Boue-Grabot et
al., 1998 ), we observed no evidence of GABA-evoked current mediated by
endogenous GABAC receptors in control neurons. In
contrast to previous reports of no desensitization of
1 subunits expressed in Xenopus
oocytes (Cutting et al., 1991 ), our
1-GFP-neurons exhibited slow but significant
desensitization during GABA application. Significant desensitization of
the GABAC receptors has also been seen when the
human 1 subunit is expressed in eukaryotic
hosts (Filippova et al., 1999 ). These observations suggest a difference
in processing of the receptor protein between the eukaryotic and the
Xenopus expression systems. However, within the limitation
of the rather slow perfusion used by us, the
GABAC receptors expressed in hippocampal neurons
retain the fundamental pharmacological and kinetic properties of
GABAC receptors that have been well described previously.
In neurons rendered hyperexcitable by chronic
kynurenate-Mg2+ treatment,
Ad- 1-GFP transduction dramatically altered the
action potential firing pattern and reduced the frequency of
spontaneous action potentials. The bursting pattern of paroxysmal
action potential firing disappeared, and the overall action potential
rate decreased to control levels. Application of CACA caused a
hyperpolarizing shift in membrane potential, confirming the expression
of GABAC receptors in these cells. Because forced
expression of GABAC receptors abolished the
hyperexcitability, we expected selective blockade of the
GABAC receptors by I4AA to return the neurons to
the hyperexcitable state. Surprisingly, I4AA alone had little effect on
the spontaneous action potential rate. Bicuculline blockade of
endogenous GABAA receptors in these same neurons
also did not reestablish the hyperexcitable state. A technical reason
for failure of the selective antagonists to reestablish
hyperexcitability is unlikely. Although a high concentration of GABA
could compete off the competitive antagonists, the proper summation of
pharmacologically separated component currents equals the total current
density (Fig. 6), indicating that under our experimental conditions,
both bicuculline and I4AA completely blocked their respective
receptors. Blockade of both GABAC and
GABAA receptors by coapplication of both
selective antagonists or application of picrotoxin alone was able to
render the neurons once again hyperexcitable, but even these neurons
had a lower frequency of spontaneous action potentials than did
nontransduced or control Ad-GFP-transduced cells. These observations
suggest that suppression of hyperexcitability by
Ad- 1-GFP is not caused solely by the
expression of additional inhibitory receptors but depends, at least in
part, on other, unknown, alterations in neuronal excitability.
Neuronal hyperexcitability in the chronic
kynurenate-Mg2+ model is caused by
enhancement of both NMDA and AMPA/kainate glutamate receptors (Van den
pol et al., 1996 ). This mechanism is consistent with the
recently demonstrated activity-dependent decrease in membrane targeting
of the AMPA receptor GluR1subunit (Lissen et al., 1998 ). Similarly,
blocking neuronal electrical activity by TTX results in elongation of
dendritic spines (Papa and Segal, 1996 ) and a decrease in
GABAA 1 and
2 subunit density (Penschuck et al., 1999 ).
Chronic activation of the GABAC receptor, which clamps the membrane potential to the chloride equilibrium
potential, would be expected to result in the loss of electrical
activity. By following this logic, the resulting electrical silence
would upregulate AMPA receptors and downregulate
GABAA receptors, increasing network excitability.
This is the opposite of what we observed. Moreover, because the effect
of chronic kynurenate-Mg2+ blockade is
virtually to abolish spontaneous electrical activity, activation of
GABAC receptors could have little additional
effect on electrical activity in this culture system. An interesting possibility is that under our culture condition, stimulation of the
GABAC receptors resulted in membrane
depolarization overcoming the glutamate blockade. If this were the
case, enhanced electrical activity could have resulted in the
upregulation of GABAA receptors.
In Ad- 1-GFP neurons cultured in standard medium, pharmacological
separation of the total current evoked by GABA into components mediated
by the GABAA and the GABAC
receptors demonstrated an unexpected induction of
GABAA receptor-mediated current density. Although
it is possible that this effect is simply the result of reduced
neuronal activity caused by expression of GABAC
receptors, neither inhibition of electrical activity (by TTX) nor
inhibition of synaptic transmission (by elevated
Mg2+) was sufficient to enhance current
density (Fig. 6C). Additionally, electrical silence has been
reported to reduce GABAA receptor 1 and 2 subunit
expression when examined by in situ hybridization (Penschuck
et al., 1999 ), and excessive depolarization (by elevated K+ or glutamate stimulation of cerebellar
granule neurons) increases GABAA subunit
transcription (Gault and Siegel, 1997 , 1998 ). Both of these effects are
in the wrong direction and fail to account for our observations.
Induction of GABAA receptors by Ad- 1-GFP must
be mediated by signals other than membrane potential.
A recent study indicates that Ig-neuregulin, a member of the epidermal
growth factor superfamily that activates receptor tyrosine kinase,
selectively increases GABAA receptor expression
via induction of the 2 subunit (Rieff et al.,
1999 ). Insulin, another growth factor well known to activate receptor
tyrosine kinase, rapidly recruits GABAA receptors
from the cytoplasmic to postsynaptic domains, increasing the amplitude
of GABAA receptor-mediated mIPSC (Wan et al.,
1997 ). It is possible that GABAC receptor
expression-mediated induction of GABAA receptors
involves this or similar intracellular signal transduction pathways.
GABAC receptor-dependent post-translational modification of GABAA receptors is another
possible mechanism for this effect.
Regardless of the precise mechanism, Ad- 1-GFP
reversed neuronal hyperexcitability and resulted in a reduction in
delayed excitotoxic neuronal death. Our results are consistent with a previous observation that GABAergic neocortical neurons are resistant to NMDA receptor-mediated injury (Tecoma and Choi, 1989 ). Exogenous administration of diazepam, an allosteric GABA potentiator, also has
been shown to reduce postischemic and traumatic neuronal death in
vivo (Schwartz et al., 1995 ; O'Dell et al., 2000 ). Because generalized augmentation of GABAergic inhibition, whether
pharmacologically or by gene targeting, may impair normal synaptic
plasticity (Levkovitz et al., 1999 ), there may be a strong advantage
for a regional rather than a general enhancement of inhibition.
Delivery of adenovirus through direct stereotactic injection might
allow expression of virally transduced GABAC
receptors in a sharply restricted subset of neurons, augmenting
endogenous GABA receptor-mediated neuroprotection without the side
effects of conventional drug therapy.
We focused on a forced expression of inhibitory GABA receptors to
suppress hyperexcitability, but other mechanisms could be used. For
example, increased GABAergic inhibition by enhancement of presynaptic
release in transgenic mice overexpressing superoxide results in
resistance to systemic kainic acid-induced seizures (Levkovitz et al.,
1999 ). Overexpression of a chloride transporter, forcing the chloride
reversal potential to become more negative (Staley et al., 1996 ), is
another approach. Excitability can be reduced by viral expression of
inwardly rectifying potassium channels with a consequent increase in
the threshold for action potential generation (Ehrengruber et al.,
1997 ; Johns et al., 1999 ). Because activation of the classical MAP
kinases (Murray et al., 1998 ) may mediate delayed neuronal death,
expression of a dominant-negative MAP kinase mutant might render
neurons resistant to excitotoxic death. Finally, a deeper understanding
of the genetic basis of epilepsy could lead to a mechanism-based gene
therapy. For example, defects in channel proteins such as GIRK2,
GluRB, or Kv1.1 have been implicated as possible causes of
epilepsy (Noebles, 1996 ). Targeted corrections of such defects might be
possible in the future.
 |
FOOTNOTES |
Received Nov. 22, 2000; revised Feb. 6, 2001; accepted March 2, 2001.
This work was supported by National Institutes of Health Grants GM
57578 and GM 52325. We thank Sundeep Malik and Nancy Ward for
assistance with molecular constructs.
Correspondence should be addressed to Dr. Jay Yang, Department of
Anesthesiology, University of Rochester Medical Centere, 601 Elmwood
Avenue, Rochester, NY 14642. E-mail:
jay_yang{at}urmc.rochester.edu.
 |
REFERENCES |
-
Abele AE,
Scholz KP,
Scholz WK,
Miller RJ
(1990)
Excitotoxicity induced by enhanced excitatory neurotransmission in cultured hippocampal pyramidal neurons.
Neuron
2:413-419.
-
Amin J,
Weiss DS
(1994)
Homomeric
1 GABA channels: activation properties and domains.
Receptors Channels
2:227-236[ISI][Medline]. -
Amin J,
Weiss DS
(1996)
Insights into the activation mechanism of
1 GABA receptors obtained by coexpression of wild type and activation-impaired subunits.
Proc R Soc Lond B Biol Sci
263:273-282[Medline]. -
Bett AJ,
Haddara W,
Prevec L,
Graham FL
(1994)
An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.
Proc Natl Acad Sci USA
91:8802-8806[Abstract/Free Full Text].
-
Bormann J
(2000)
The "ABC" of GABA receptors.
Trends Pharmacol Sci
21:16-19[Medline].
-
Bormann J,
Feigenspan A
(1995)
GABAC receptors.
Trends Neurosci
18:515-519[ISI][Medline].
-
Boue-Grabot E,
Roudbaraki M,
Bascles L,
Tramu G,
Block B,
Garret M
(1998)
Expression of GABA receptor
subunits in rat brain.
J Neurochem
70:899-907[ISI][Medline]. -
Cheng Q,
Yang J
(2000)
Subsynaptic targeting of adenovirus-transduced GABAA but not GABAC receptor subunits in hippocampal neurons.
Soc Neurosci Abstr
26:1656.
-
Cutting GR,
Lu L,
O'Hara BF,
Kasch LM,
Montrose-Rafizadeh C,
Donovan DM,
Shimada S,
Antonarakis SE,
Guggino WB,
Uhl GR,
Kazazian Jr HH
(1991)
Cloning of the
-aminobutyric acid (GABA) 1 cDNA: a GABA receptor subunit highly expressed in the retina.
Proc Natl Acad Sci USA
88:2673-2677[Abstract/Free Full Text]. -
Ehrengruber MU,
Doupnik CA,
Xu Y,
Garvey J,
Jasek MC,
Lester HA,
Davidson N
(1997)
Activation of heteromeric G protein-gated inward rectifier K channel over-expressed by adenovirus gene transfer inhibits the excitability of hippocampal neurons.
Proc Natl Acad Sci USA
94:7070-7095[Abstract/Free Full Text].
-
Enz R,
Cutting GR
(1999)
GABAC receptor
subunits are heterogeneously expressed in the human CNS and form homo- and heterooligomers with distinct properties.
Eur J Neurosci
11:41-50[ISI][Medline]. -
Filippova N,
Dudley R,
Weiss DS
(1999)
Evidence for phosphorylation-dependent internalization of recombinant human
1 GABAC receptors.
J Physiol (Lond)
518:385-399[Abstract/Free Full Text]. -
Friedman LK,
Pellegrini-Giampietro DE,
Sperber EF,
Bennet MV,
Moshe SL,
Zukin RS
(1994)
Kainate-induced status epilepticus alters glutamate and GABAA receptor gene expression in adult rat hippocampus: an in situ hybridization study.
J Neurosci
14:2697-2707[Abstract].
-
Furshpan EJ,
Potter DD
(1989)
Seizure-like activity and cellular damage in rat hippocampal neurons in cell culture.
Neuron
3:199-207[ISI][Medline].
-
Gault LM,
Siegel RE
(1997)
Expression of the GABAA receptor
subunit is selectively modulated by depolarization in cultured rat cerebellar granule neurons.
J Neurosci
17:2391-2399[Abstract/Free Full Text]. -
Gault LM,
Siegel RE
(1998)
NMDA receptor stimulation selectively initiates GABAA receptor delta subunit mRNA expression in cultured rat cerebellar granule neurons.
J Neurochem
70:1907-1915[Medline].
-
Gibbs JW,
Sombati S,
Delorenzo RJ,
Coulter DA
(1997)
Physiological and pharmacological alterations in postsynaptic GABAA receptor function in a hippocampal culture model of chronic spontaneous seizures.
J Neurophysiol
77:2139-2152[Abstract/Free Full Text].
-
Griesbeck O,
Korte M,
Gravel C,
Bonhoeffer T,
Thoenen H
(1997)
Rapid gene transfer into cultured hippocampal neurons and acute hippocampal slice using adenoviral vectors.
Mol Brain Res
44:171-177[Medline].
-
Hackam AS,
Wang TL,
Guggino WB,
Cutting GR
(1997)
The N-terminal domain of human GABA receptor
1 subunits contains signals for homoligomeric and heteroligomeric interaction.
J Biol Chem
272:13750-13757[Abstract/Free Full Text]. -
Hackam AS,
Wang TL,
Guggino WB,
Cutting GR
(1998)
Sequences in the amino termini of GABA
and GABAA subunits specify their selective interaction in vitro.
J Neurochem
70:40-46[ISI][Medline]. -
Hanley JG,
Koulen P,
Bedford F,
Gordon-Weeks PR,
Moss SJ
(1999)
The protein MAP-1B links GABAC receptors to the cytoskeleton at retinal synapses.
Nature
397:66-69[Medline].
-
Hevers W,
Luddens H
(1998)
The diversity of GABAA receptors.
Mol Neurobiol
18:35-86[ISI][Medline].
-
Jallon P
(1997)
The problem of intractability: the continuing need for new medical therapies in epilepsy.
Epilepsia
38:S37-S42.
-
Johns DC,
Marx R,
Mains RE,
O'Rourke B,
Marban E
(1999)
Inducible genetic suppression of neuronal excitability.
J Neurosci
19:1691-1697[Abstract/Free Full Text].
-
Jones MV,
Sahara Y,
Dzubay JA,
Westbrook GL
(1998)
Defining affinity with the GABAA receptor.
J Neurosci
18:8590-8604[Abstract/Free Full Text].
-
Levkovitz Y,
Avignone E,
Groner Y,
Segal M
(1999)
Upregulation of GABA neurotransmission suppresses hippocampal excitability and prevents long-term potentiation in transgenic superoxide dismutase-overexpressing mice.
J Neurosci
19:10977-10984[Abstract/Free Full Text].
-
Lissen DV,
Gomperts SN,
Carroll RC,
Christine CW,
Kalman D,
Kitamura M,
Hardy S,
Nicoll RA,
Malenka RC,
Zastrow MV
(1998)
Activity differentially regulates the surface expression of synaptic AMPA and NMDA glutamate receptors.
Proc Natl Acad Sci USA
95:7097-7102[Abstract/Free Full Text].
-
Loscher W
(1998)
New vision in the pharmacology of anticonvulsants.
Eur J Pharmacol
342:1-13[ISI][Medline].
-
Mody I
(1998)
Ion channels in epilepsy.
Annu Rev Pharmacol Toxicol
38:321-350[ISI][Medline].
-
Murray B,
Alessandrini A,
Cole AJ,
Yee AG,
Furshpan EJ
(1998)
Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity.
Proc Natl Acad Sci USA
95:11975-11980[Abstract/Free Full Text].
-
Noebles JL
(1996)
Targeting epilepsy genes.
Neuron
16:241-244[ISI][Medline].
-
O'Dell DM,
Gibson CH,
Wilson MS,
DeFord SM,
Hamm RJ
(2000)
Positive and negative modulation of the GABAA receptor and outcome after traumatic brain injury in rats.
Brain Res
861:325-332[Medline].
-
Papa M,
Segal M
(1996)
Morphological plasticity in dendritic spines of cultured hippocampal neurons.
Neuroscience
71:1005-1011[ISI][Medline].
-
Penschuck S,
Paysan J,
Giorgetta O,
Fritschy JM
(1999)
Activity-dependent regulation of GABAA receptors.
Ann NY Acad Sci
868:654-666[ISI][Medline].
-
Rice A,
Rafiq A,
Shapiro SM,
Jakoi ER,
Coulter DA,
DeLorenzo RJ
(1996)
Long-lasting reduction of inhibitory function and
-aminobutyric acid type A receptor subunit mRNA expression in a model of temporal lobe epilepsy.
Proc Natl Acad Sci USA
93:9665-9669[Abstract/Free Full Text]. -
Rieff HI,
Raetzman LT,
Sapp DW,
Yeh HH,
Siegel RE,
Corfas G
(1999)
Neuregulin induces GABAA receptor subunit expression and neurite outgrowth in cerebellar granule cells.
J Neurosci
19:10757-10766[Abstract/Free Full Text].
-
Schwartz RD,
Yu X,
Katzman MR,
Haydon-Hixson DM,
Perry JM
(1995)
Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum.
J Neurosci
15:529-539[Abstract].
-
Shimada S,
Cutting G,
Uhl GR
(1992)
-Aminobutyric acid A or C receptor? -Aminobutyric acid 1 receptor RNA induces bicuculline-, barbiturate-, and benzodiazepine-insensitive -aminobutyric acid responses in Xenopus oocytes.
Mol Pharmacol
41:683-687[Abstract]. -
Smith GM,
Berry RL,
Yang J,
Tanelian D
(1997)
Electrophysiological analysis of dorsal root ganglion neurons pre- and post-coexpression of green fluorescent protein and functional 5-HT3 receptor.
J Neurophysiol
77:3115-3121[Abstract/Free Full Text].
-
Staley K,
Smith R,
Schaak J,
Wilcox C,
Jentsch TJ
(1996)
Alteration of GABAA receptor following gene transfer of the CLC-2 chloride channel.
Neuron
17:543-551[ISI][Medline].
-
Strata F,
Cherubini E
(1994)
Transient expression of a novel type of GABA response in rat CA3 hippocampal neurones during development.
J Physiol (Lond)
480:493-503[ISI][Medline].
-
Tecoma ES,
Choi DW
(1989)
GABAergic neocortical neurons are resistant to NMDA receptor-mediated injury.
Neurology
39:676-682[Abstract/Free Full Text].
-
Van den pol AN,
Obrietan K,
Belousov A
(1996)
Glutamate hyperexcitability and seizure-like activity throughout the brain and spinal cord upon relief from chronic glutamate receptor blockade in culture.
Neuroscience
74:653-674[ISI][Medline].
-
Wan Q,
Xiong ZG,
Man HY,
Ackerley CA,
Braunton J,
Lu WY,
Becker LE,
MacDonald JF,
Want YT
(1997)
Recruitment of functional GABAA receptors to postsynaptic domains by insulin.
Nature
686:686-690.
-
Wang TL,
Guggino WB,
Cutting GR
(1994)
A novel
-aminobutyric acid receptor subunit ( 2) cloned from human retina forms bicuculline-insensitive homooligomeric receptors in Xenopus oocytes.
J Neurosci
14:6524-6531[Abstract]. -
Wilkemeyer MF,
Smith KL,
Zarie MM,
Benke TA,
Swann JW,
Angelides KJ,
Eisensmith RC
(1996)
Adenovirus-mediated gene transfer into dissociated and explant cultures of rat hippocampal neurons.
J Neurosci Res
43:161-174[ISI][Medline].
|